As of 2025-06-29, the Relative Valuation of Kolon TissueGene Inc (950160.KQ) is (9,822.71) KRW. This relative valuation is based on P/E multiples. With the latest stock price at 41,500.00 KRW, the upside of Kolon TissueGene Inc based on Relative Valuation is -123.7%.
The range of the Relative Valuation is (9,359.43) - (9,578.36) KRW.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.9x - 31.8x | 27.4x |
| Forward P/E multiples | 21.3x - 24.5x | 22.9x |
| Fair Price | (9,359.43) - (9,578.36) | (9,822.71) |
| Upside | -122.6% - -123.1% | -123.7% |
| Date | P/E |
| 2025-06-27 | -144,850.98 |
| 2025-06-26 | -142,756.75 |
| 2025-06-25 | -148,864.92 |
| 2025-06-24 | -156,718.29 |
| 2025-06-23 | -159,161.56 |
| 2025-06-20 | -157,067.33 |
| 2025-06-19 | -160,906.75 |
| 2025-06-18 | -133,332.71 |
| 2025-06-17 | -139,964.44 |
| 2025-06-16 | -144,327.42 |
| 2025-06-13 | -128,620.69 |
| 2025-06-12 | -137,521.17 |
| 2025-06-11 | -139,615.40 |
| 2025-06-10 | -134,379.83 |
| 2025-06-09 | -135,601.46 |
| 2025-06-05 | -135,950.50 |
| 2025-06-04 | -138,568.29 |
| 2025-06-02 | -137,521.17 |
| 2025-05-30 | -141,709.63 |
| 2025-05-29 | -141,709.63 |
| 2025-05-28 | -141,709.63 |
| 2025-05-27 | -143,803.87 |